The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 26, 2016

Filed:

Jul. 09, 2009
Applicants:

Anders Bach, Valby, DK;

Kristian Stromgaard, Roskilde, DK;

Inventors:

Anders Bach, Valby, DK;

Kristian Stromgaard, Roskilde, DK;

Assignee:

University of Copenhagen, Copenhagen, DK;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/08 (2006.01); C07K 7/06 (2006.01); C12N 5/071 (2010.01); A61P 25/00 (2006.01); A61K 38/07 (2006.01); A61K 47/48 (2006.01); C07K 5/103 (2006.01); C07K 5/113 (2006.01); C07K 14/705 (2006.01);
U.S. Cl.
CPC ...
A61K 38/07 (2013.01); A61K 38/08 (2013.01); A61K 47/48246 (2013.01); C07K 5/1008 (2013.01); C07K 5/1021 (2013.01); C07K 14/70571 (2013.01);
Abstract

The present invention is directed to the provision of small molecule inhibitors of the PSD-95/NMDA receptor interaction, employing an undecapeptide corresponding to the C-terminal of the NMDA as a template for finding lead candidates. A compound (NMDAR/PSD-95 inhibitor) of the invention includes a peptide or peptide analogue comprising at least four peptide bonded residues having the sequence YTXV or YSXV, wherein Y is selected from among E, Q, and A, or an analogue thereof and X is selected from among A, Q, D, N, N-Me-A, N-Me-Q, N-Me-D, and N-Me-N or an analogue thereof, wherein an amino-terminal residue of the peptide is N-alkylated. Alternatively the compound of the invention comprises a first peptide or peptide analogue linked to a second peptide or peptide analogue by a linker, where the first and second peptide or peptide analogue each comprise at least four peptide bonded residues having the sequence YTXV or YSXV, wherein Y is selected from among E, Q, and A, or an analogue thereof, and X is selected from among A, Q, D, N, N-Me-A, N-Me-Q, N-Me-D, and N-Me-N or an analogue thereof.


Find Patent Forward Citations

Loading…